Par, Purdue Settle IP Claims In OxyContin Antitrust MDL

Par Pharmaceutical Cos. Inc. has settled a suit alleging its proposed generic OxyContin infringed Purdue Pharma LP patents for a tamper-resistant form of the widely abused painkiller, according to a consent...

Already a subscriber? Click here to view full article